OSR Health, Inc. (OSRH)
OSRH is quoted over the counter, not listed on an exchange. OSR Health, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | OSRH, quoted over the counter |
| SEC CIK | 0001840425 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Business address | Bellevue, WA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-13 |
| Cash and burn | $1.5M cash; operating cash flow -$1.8M a quarter. | Report 2026-06-30 |
| Shares outstanding | 35,258,692 (2026-11-13); 25,672,788 a year earlier; 9,055,000 three years earlier. | Cover page 2026-11-13 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 3 (8-K item 3.01) | 8-K 2026-10-28 |
| Delisting | 25-NSE filed | 25-NSE 2025-02-18 |
| Auditor | WithumSmith+Brown, PC, New York, New York, United States; changed auditors 1 time in 24 months | 8-K 4.01 2026-11-13 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $316K | -$1.0M | -$2.4M | $1.5M | $2.6M | $1.8M | 10-Q 2026-08-14 |
| Q1 2026 2026-03-31 | $484K | -$3.5M | -$1.0M | $1.6M | $2.7M | $2.6M | 10-Q 2026-05-13 |
| Q4 2025 2025-12-31 | $381K | -$7.2M | -$1.1M | $1.7M | $2.3M | $2.9M | 10-K 2026-03-31 |
| Q3 2025 2025-09-30 | $628K | -$3.2M | -$2.7M | $2.2M | $1.9M | $3.4M | 10-Q 2025-11-12 |
| Q2 2025 2025-06-30 | $1.1M | -$5.2M | -$483K | $1.6M | $2.4M | $3.6M | 10-Q 2026-08-14 |
| Q1 2025 2025-03-31 | $761K | -$11.4M | -$64K | $1.6M | $2.1M | $3.4M | 10-Q 2026-05-13 |
| Q4 2024 2024-12-31 | $915K | -$2.0M | -$181K | $342K | $2.3M | $3.5M | 10-K 2026-03-31 |
| Q3 2024 2024-09-30 | $823K | -$231K | -$686K | $12K | $3.9M | Needs four quarters | 10-Q 2025-11-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2025-06-27 |
| Latest annual report | 10-K | 2026-03-31 |
| Latest quarterly / interim | 10-Q | 2026-11-13 |
| Latest current report | 8-K | 2026-11-13 |
| Latest proxy | DEF 14A | 2026-07-16 |
Source: SEC EDGAR submissions feed, 228 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier